New Brighton, MN, United States of America

Jerome T Hartlaub

This inventor holds 41 USPTO granted patents and 1 published patent application, primarily in Implantable Medical Devices. Top assignees: Medtronic, Inc., Honeywell G.m.b.h., Other. Active years: 1976-2010.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jerome T Hartlaub. Retrieved from https://idiyas.com/inventor/jerome-t-hartlaub

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 41 

% Patents Active = 90.2

Average Co-Inventor Count = 1.8

ph-index = 23

Forward Citations = 3,127(Granted Patents)


Location History:

  • Saint Paul, MN (US) (2001 - 2009)
  • New Brighton, MN (US) (1976 - 2010)

Company Filing History:


Years Active: 1976-2010

Loading Chart...
Areas of Expertise:
Drug Therapy Control
Temperature Sensing
Implantable Pump
Audible Sound Communication
Firmware Storage
Tachyarrhythmia Pacer
Programmable Pacemaker
Microenvironment Infusion
Non-Conformance Monitoring
Fiber Optic Sensors
Digital Cardiac Pacemaker
Body Stimulation Systems
41 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Jerome T Hartlaub

Introduction: Jerome T Hartlaub is an influential inventor based in New Brighton, MN, celebrated for his remarkable contributions to the field of medical technology. With a portfolio of 41 patents, Hartlaub has dedicated his career to enhancing drug delivery systems, ensuring patient safety and efficacy in treatment regimens.

Latest Patents: Among Hartlaub's recent innovations are two significant patents aimed at improving the reliability and effectiveness of implantable drug infusion pumps. The first, titled "Method and apparatus to control drug therapy dosages in an implantable pump," introduces a microprocessor-controlled system that allows patients to self-administer additional dosages while minimizing the risk of overdosage or underdosage. The programmed dosage characteristic limitations offer a safeguard by defining the maximum and minimum amounts of medication that can be administered within a specified timeframe.

The second patent, "Method and apparatus to sense temperature in an implantable pump," enhances the functionality of drug infusion pumps by monitoring their temperature. This innovation ensures the consistency of drug delivery and can facilitate temperature-related modifications to therapy. By utilizing simple sensors, Hartlaub's design allows for real-time temperature data collection, which is critical for optimal patient care.

Career Highlights: Hartlaub's professional journey includes significant tenures at renowned companies such as Medtronic, Inc. and Honeywell GmbH. His work has not only advanced technological standards in medical devices but has also set new benchmarks for safety and performance in drug delivery systems.

Collaborations: Throughout his career, Hartlaub has collaborated with notable professionals, including coworkers David L Thompson and Daniel R Greeninger. These partnerships have fostered a rich exchange of ideas and innovations, reinforcing the importance of teamwork in the advancement of technology.

Conclusion: Jerome T Hartlaub stands out as a prominent inventor in the medical technology arena, with a strong emphasis on improving drug delivery systems through innovative designs. His dedication to enhancing patient safety and treatment efficacy is reflected in his extensive portfolio of patents, establishing him as a key figure in the industry. As technology continues to evolve, Hartlaub’s contributions will likely inspire future developments in medical devices.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…